Smoke-Free Homes Intervention for Smoking Cessation
(SFH 5A RCT Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to test whether the integration of a smoke-free homes intervention into the clinical guidelines for tobacco cessation can encourage sustained smoking cessation in low-income primary care patients. The intervention consists of five components, three interactive mailings and two coaching calls, focused on creating home and vehicle(s) smoking bans among smokers.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Smoke-Free Homes treatment for smoking cessation?
The Smoke-Free Homes Program has been shown to be effective in promoting smoke-free environments in low-income populations, as evidenced by its successful implementation in 2-1-1 call centers. Additionally, interventions that combine smoke-free policies with tobacco dependence treatments are noted to be more effective, suggesting that the Smoke-Free Homes intervention could support smoking cessation efforts.12345
Is the Smoke-Free Homes Intervention safe for humans?
How is the Smoke-Free Homes intervention treatment different from other smoking cessation treatments?
The Smoke-Free Homes intervention is unique because it focuses on creating smoke-free environments in homes, particularly in low-income and supportive housing settings, rather than directly targeting individual smoking habits. This approach aims to reduce secondhand smoke exposure and encourage voluntary adoption of smoke-free policies, which can indirectly support smoking cessation.124910
Research Team
Michelle Kegler, PhD
Principal Investigator
Emory University
Eligibility Criteria
This trial is for adult smokers referred by a primary care physician from a participating health center in South Georgia, who have smoked recently but aren't in another cessation program. Participants must speak and understand English, be the only person from their household to join, and not be pregnant or unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Smoke-Free Homes intervention, including interactive mailings and coaching calls, and may connect to the quitline
Follow-up
Participants are monitored for smoking cessation and smoke-free home establishment at six and twelve months
Treatment Details
Interventions
- Smoke-Free Homes intervention
- Smoke-Free Homes Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Michelle C. Kegler
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator